Quinidine Sulfate Market to see Huge Growth by 2029
The global quinidine sulfate market is anticipated to grow at a significant CAGR during the forecast period. Quinidine sulfate is used for the treatment of certain types of irregular heartbeats. It is in a class of medications called antiarrhythmic medications and works by making the heart more resistant to abnormal activity. The major factor driving the demand for quinidine sulfate is the increasing prevalence of arrhythmia and other diseases such as malaria that require quinidine sulfate treatment across the globe.
Moreover, the growth of the
market can also be attributed to the increasing awareness of the usage and
appropriate dosage of quinidine sulfate supplements among people globally.
Additionally, the function of quinidine sulfate involves blocking the fast
inward sodium current that is dependent upon the use. For instance, at higher
heart rates, the block increases, and at lower heart rates, the block
decreases. Further, the growth of the market is hampered due to side effects
associated with quinidine sulfate such as diarrhea, nausea, vomiting, loss of
appetite, stomach pain/cramps, among others.
Some major players in the market include Pfizer Inc., Novartis
International AG, and Lupin Ltd., among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in March 2019, Avanir Pharmaceuticals,
Inc. announced the results from the first study of its phase 3 clinical
development program investigating the efficacy, safety, and tolerability of
AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for
the treatment of moderate-to-severe agitation in patients with Alzheimer's
dementia.
To Request a Sample of our Report on Quinidine Sulfate
Market: https://www.omrglobal.com/request-sample/quinidine-sulfate-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
Segment Covered-
·
By Route of Administration
·
By Application
·
By End-User
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Pfizer Inc., Novartis International AG, and Lupin
Ltd., among others.
Quinidine Sulfate Market Report by Segment
By Route of Administration
·
Oral Administration
·
Intravenous Administration
·
Others
By Application
·
Arrhythmias
·
Malaria
·
Others
By End-User
·
Pediatrics
·
Adults
A
full Report of Quinidine Sulfate Market is Available @ https://www.omrglobal.com/industry-reports/quinidine-sulfate-market
Quinidine Sulfate Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment